Abstract
Purpose
Patients with primary or metastatic brain tumors often require intensive end-of-life care, for which place of death may serve as a quality metric. Death at home or hospice is considered a more “ideal” location. Comprehensive information on place of death of people with brain tumors is lacking.
Methods
Using CDC Wonder Database data, those who died in the USA from a solid cancer from 2003 to 2016 were included and place of death for those with primary brain, brain metastases, and solid non-brain tumors were compared. Multivariate logistic regression tested for disparities in place of death.
Results
By 2016, 51.1% of patients with primary brain tumors and 45.2% with brain metastases died at home. 15.9% of patients with primary brain tumors and 23.6% with brain metastases died in the hospital. Black patients were least likely to die at home or hospice. For patients with primary brain tumors, being married (OR = 2.25 (95%CI 2.16–2.34), p < 0.01) and having an advanced degree (OR = 1.204 (95%CI 1.15–1.26), p < 0.01) increased odds of home/hospice death; older age (OR = 0.50 (95%CI 0.46–0.54), p < 0.01) decreased odds for home/hospice death. For patients with brain metastases, being married (OR = 2.19 (95%CI 2.11–2.26), p < 0.01) increased odds of home/hospice death and male sex (OR = 0.87 (095%CI .85–0.89), p < 0.01) and older age (OR = 0.59 (95%CI 0.47–0.75), p < 0.01) decreased odds of home/hospice death.
Conclusion
Disparities exist in place of death in the brain tumor population. Focused interventions are indicated to increase the utilization of hospice in those with metastatic cancer, under-represented minority groups, and the elderly population.
Similar content being viewed by others
Data availability
Data is publicly available.
Code availability
Not applicable.
References
Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71:7–33. https://doi.org/10.3322/caac.21654
Batchelor TT, Byrne TN (2006) Supportive care of brain tumor patients. Hematol Oncol Clin North Am 20:1337–1361. https://doi.org/10.1016/j.hoc.2006.09.013
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742. https://doi.org/10.1056/NEJMoa1000678
Amano K, Morita T, Tatara R, Katayama H, Uno T, Takagi I (2015) Association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of care at the end of life. J Palliat Med 18:270–273. https://doi.org/10.1089/jpm.2014.0132
Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK et al (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300:1665–1673. https://doi.org/10.1001/jama.300.14.1665
Gomes B, Higginson IJ, Calanzani N, Cohen J, Deliens L, Daveson BA, Bechinger-English D, Bausewein C, Ferreira PL, Toscani F et al (2012) Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands. Portugal and Spain Ann Oncol 23:2006–2015. https://doi.org/10.1093/annonc/mdr602
Macmillan Cancer Support. No regrets: how talking more openly about death could help people die well. Available online: https://www.macmillan.org.uk/_images/no-regrets-talking-about-death-report_tcm9-311059.pdf (accessed on
Chino F, Kamal AH, Leblanc TW, Zafar SY, Suneja G, Chino JP (2018) Place of death for patients with cancer in the United States, 1999 through 2015: racial, age, and geographic disparities. Cancer 124:4408–4419. https://doi.org/10.1002/cncr.31737
Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B et al (2016) Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. JAMA 315:272–283. https://doi.org/10.1001/jama.2015.18603
Kalseth J, Theisen OM (2017) Trends in place of death: the role of demographic and epidemiological shifts in end-of-life care policy. Palliat Med 31:964–974. https://doi.org/10.1177/0269216317691259
Centers for Disease Control and Prevention, National Center for Health Statistics. CDC Wonder Database. Available online: https://wonder.cdc.gov/ (accessed on 3/5/2019).
Chino F, Kamal AH, Chino J, LeBlanc TW (2019) Disparities in place of death for patients with hematological malignancies, 1999 to 2015. Blood Adv 3:333–338. https://doi.org/10.1182/bloodadvances.2018023051
Triebel KL, Martin RC, Nabors LB, Marson DC (2009) Medical decision-making capacity in patients with malignant glioma. Neurology 73:2086–2092. https://doi.org/10.1212/WNL.0b013e3181c67bce
Sizoo EM, Taphoorn MJ, Uitdehaag B, Heimans JJ, Deliens L, Reijneveld JC, Pasman HR (2013) The end-of-life phase of high-grade glioma patients: dying with dignity? Oncologist 18:198–203. https://doi.org/10.1634/theoncologist.2012-0247
Sizoo EM, Pasman HR, Buttolo J, Heimans JJ, Klein M, Deliens L, Reijneveld JC, Taphoorn MJ (2012) Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer 48:226–232. https://doi.org/10.1016/j.ejca.2011.11.010
Musella A, DeVitto R, Anthony M, Elliott Mydland D (2021) The importance of shared decision-making for patients with glioblastoma. Patient Prefer Adherence 15:2009–2016. https://doi.org/10.2147/PPA.S314792
Corell A, Guo A, Vecchio TG, Ozanne A, Jakola AS (2021) Shared decision-making in neurosurgery: a scoping review. Acta Neurochir (Wien) 163:2371–2382. https://doi.org/10.1007/s00701-021-04867-3
Brom L, De Snoo-Trimp JC, Onwuteaka-Philipsen BD, Widdershoven GA, Stiggelbout AM, Pasman HR (2017) Challenges in shared decision making in advanced cancer care: a qualitative longitudinal observational and interview study. Health Expect 20:69–84. https://doi.org/10.1111/hex.12434
Ferris FD, Bruera E, Cherny N, Cummings C, Currow D, Dudgeon D, Janjan N, Strasser F, von Gunten CF, Von Roenn JH (2009) Palliative cancer care a decade later: accomplishments, the need, next steps — from the American Society of Clinical Oncology. J Clin Oncol 27:3052–3058. https://doi.org/10.1200/JCO.2008.20.1558
Agrawal M, Emanuel EJ (2002) Attending to psychologic symptoms and palliative care. J Clin Oncol 20:624–626. https://doi.org/10.1200/JCO.2002.20.3.624
Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR, Postma TJ, Deliens L, Grant R, McNamara S, Grisold W et al (2014) End of life care in high-grade glioma patients in three European countries: a comparative study. J Neurooncol 120:303–310. https://doi.org/10.1007/s11060-014-1548-5
Wright AA, Keating NL, Ayanian JZ, Chrischilles EA, Kahn KL, Ritchie CS, Weeks JC, Earle CC, Landrum MB (2016) Family perspectives on aggressive cancer care near the end of life. JAMA 315:284–292. https://doi.org/10.1001/jama.2015.18604
Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, Mor V (2004) Family perspectives on end-of-life care at the last place of care. JAMA 291:88–93. https://doi.org/10.1001/jama.291.1.88
Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG (2010) End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 28:1203–1208. https://doi.org/10.1200/JCO.2009.25.4672
Stein RA, Sharpe L, Bell ML, Boyle FM, Dunn SM, Clarke SJ (2013) Randomized controlled trial of a structured intervention to facilitate end-of-life decision making in patients with advanced cancer. J Clin Oncol 31:3403–3410. https://doi.org/10.1200/JCO.2011.40.8872
Taylor JS, Rajan SS, Zhang N, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH (2017) End-of-life racial and ethnic disparities among patients with ovarian cancer. J Clin Oncol 35:1829–1835. https://doi.org/10.1200/JCO.2016.70.2894
Loggers ET, Maciejewski PK, Paulk E, DeSanto-Madeya S, Nilsson M, Viswanath K, Wright AA, Balboni TA, Temel J, Stieglitz H et al (2009) Racial differences in predictors of intensive end-of-life care in patients with advanced cancer. J Clin Oncol 27:5559–5564. https://doi.org/10.1200/JCO.2009.22.4733
Gomes B, Higginson IJ (2006) Factors influencing death at home in terminally ill patients with cancer: systematic review. BMJ 332:515–521. https://doi.org/10.1136/bmj.38740.614954.55
Reinhard S et al. Valuing the invaluable 2015 update - AARP. https://www.aarp.org/content/dam/aarp/ppi/2015/valuing-the-invaluable-2015-update-new.pdf
Johnson KS, Kuchibhatla M, Tulsky JA (2008) What explains racial differences in the use of advance directives and attitudes toward hospice care? J Am Geriatr Soc 56:1953–1958. https://doi.org/10.1111/j.1532-5415.2008.01919.x
Emanuel EJ, Fairclough DL, Slutsman J, Alpert H, Baldwin D, Emanuel LL (1999) Assistance from family members, friends, paid care givers, and volunteers in the care of terminally ill patients. N Engl J Med 341:956–963. https://doi.org/10.1056/NEJM199909233411306
Jarosek SL, Shippee TP, Virnig BA (2016) Place of death of individuals with terminal cancer: new insights from Medicare hospice place-of-service codes. J Am Geriatr Soc 64:1815–1822. https://doi.org/10.1111/jgs.14269
Erickson SE, Vasilevskis EE, Kuzniewicz MW, Cason BA, Lane RK, Dean ML, Rennie DJ, Dudley RA (2011) The effect of race and ethnicity on outcomes among patients in the intensive care unit: a comprehensive study involving socioeconomic status and resuscitation preferences. Crit Care Med 39:429–435. https://doi.org/10.1097/CCM.0b013e318206b3af
Forst D, Adams E, Nipp R, Martin A, El-Jawahri A, Aizer A, Jordan JT (2018) Hospice utilization in patients with malignant gliomas. Neuro Oncol 20:538–545. https://doi.org/10.1093/neuonc/nox196
Miesfeldt S, Murray K, Lucas L, Chang CH, Goodman D, Morden NE (2012) Association of age, gender, and race with intensity of end-of-life care for Medicare beneficiaries with cancer. J Palliat Med 15:548–554. https://doi.org/10.1089/jpm.2011.0310
Falchook, A.D.; Dusetzina, S.B.; Tian, F.; Basak, R.; Selvam, N.; Chen, R.C. (2017) Aggressive end-of-life care for metastatic cancer patients younger than age 65 years. J Natl Cancer Inst, 109, https://doi.org/10.1093/jnci/djx028.
Johnston EE, Alvarez E, Saynina O, Sanders LM, Bhatia S, Chamberlain LJ (2018) Inpatient utilization and disparities: the last year of life of adolescent and young adult oncology patients in California. Cancer 124:1819–1827. https://doi.org/10.1002/cncr.31233
Rajeshuni N, Johnston EE, Saynina O, Sanders LM, Chamberlain LJ (2017) Disparities in location of death of adolescents and young adults with cancer: a longitudinal, population study in California. Cancer 123:4178–4184. https://doi.org/10.1002/cncr.30860
Diamond EL, Russell D, Kryza-Lacombe M, Bowles KH, Applebaum AJ, Dennis J, DeAngelis LM, Prigerson HG (2016) Rates and risks for late referral to hospice in patients with primary malignant brain tumors. Neuro Oncol 18:78–86. https://doi.org/10.1093/neuonc/nov156
Gruneir A, Mor V, Weitzen S, Truchil R, Teno J, Roy J (2007) Where people die: a multilevel approach to understanding influences on site of death in America. Med Care Res Rev 64:351–378. https://doi.org/10.1177/1077558707301810
Dover LL, Dulaney CR, Fiveash JB, Williams CP, Jackson BE, Warren P, Rocque GB (2017) Hospital-based end-of-life care and costs for older patients with malignant brain tumors. JAMA Oncol 3:1581–1582. https://doi.org/10.1001/jamaoncol.2017.1624
Walbert T, Glantz M, Schultz L, Puduvalli VK (2016) Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey. J Neurooncol 126:337–345. https://doi.org/10.1007/s11060-015-1973-0
Mieno MN, Tanaka N, Arai T, Kawahara T, Kuchiba A, Ishikawa S, Sawabe M (2016) Accuracy of death certificates and assessment of factors for misclassification of underlying cause of death. J Epidemiol 26:191–198. https://doi.org/10.2188/jea.JE20150010
Barclay JS, Kuchibhatla M, Tulsky JA, Johnson KS (2013) Association of hospice patients’ income and care level with place of death. JAMA Intern Med 173:450–456. https://doi.org/10.1001/jamainternmed.2013.2773
Author information
Authors and Affiliations
Contributions
Writing: RS and MEM. Editing: RS, MEM, FC, JC. Data analysis: RS, MEM, FC, JC. Concept: RS, MEM, FC, JC.
Corresponding author
Ethics declarations
Ethics approval
This is an observational study. The Duke University Hospital Research Ethics Committee has confirmed that no ethical approval is required.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rachel Shenker and Mary Elizabeth McLaughlin are co-first authors.
Rights and permissions
About this article
Cite this article
Shenker, R.F., Elizabeth McLaughlin, M., Chino, F. et al. Disparities in place of death for patients with primary brain tumors and brain metastases in the USA. Support Care Cancer 30, 6795–6805 (2022). https://doi.org/10.1007/s00520-022-07120-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-022-07120-4